ANI Pharmaceuticals Director Matthew Leonard Receives Restricted Stock Award

This Form 4 filing reports that Matthew J. Leonard, a director of ANI Pharmaceuticals Inc. (ANIP), received a restricted stock award of 4,357 shares of common stock on May 21, 2026. The award was granted with a price per share of $0.00, indicating it was a compensation award rather than a market purchase. Following this transaction, Leonard's total holdings increased to 11,221 shares. According to footnote F1, this restricted stock award will vest in full on May 21, 2027, representing a one-year vesting period. The filing was signed by attorney-in-fact Meredith W. Cook on June 10, 2026, and reported under Section 16 of the Securities Exchange Act. This transaction represents standard director compensation through equity awards, which aligns the director's interests with shareholder value creation.